ArticleJournal of thrombosis and haemostasis : JTH2020
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations.
Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 18 citations in OpenAlex.
- Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring.Research and practice in thrombosis and haemostasis · 2023Article
- Clinical use of thrombin generation assays.Journal of thrombosis and haemostasis : JTH · 2021Review
- Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity.Biomedicines · 2021Article
- Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study.Thrombosis journal · 2021Article
- Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram.Research and practice in thrombosis and haemostasis · 2021Article
- The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review.Diagnostics (Basel, Switzerland) · 2021Review
- COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.Arteriosclerosis, thrombosis, and vascular biology · 2021Article
- Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.Thrombosis research · 2021Observational
- The role of rotational thromboelastometry in understanding the coagulation problems in COVID-19 associated critical illness.Anaesthesiology intensive therapy · 2021Review
- Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": Don't throw the baby out with the bathwater.Journal of thrombosis and haemostasis : JTH · 2020Article
- Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan.Thrombosis journal · 2020Review
- Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
8 authors at 3 institutions in 3 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.